Bolt Biotherapeutics Inc. (BOLT)

AI Score

Unlock

0.38

0.01 (2.15%)

At close: Apr 24, 2025, 3:56 PM

0.38

-0.08%

Pre-market: Apr 25, 2025, 08:14 AM EDT

Bolt Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	7.21M	9.37M	6.2M	4.26M	10.81M	9.16M	13.45M	14.84M	9.24M	10.62M	22.62M	44.02M	27.38M	23.65M	58.3M	95.48M	5.54M	17.79M	45.31M	-34.83M	34.83M	-13.63M
Short-Term Investments	40.12M	44.43M	67.5M	87.09M	91.38M	110.56M	112.42M	111.54M	159.64M	160.51M	153.72M	146.88M	158.84M	189.24M	186.69M	171.19M	17.3M	19.95M	8.04M	69.65M	n/a	27.27M
Long-Term Investments	22.88M	30.6M	23.83M	23.23M	28.18M	21.64M	31.22M	44.59M	23.94M	38.43M	47.28M	54.31M	85.35M	77.64M	65.94M	36.24M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.04M	1.27M	2.07M	1.76M	2M	3.11M	2.58M	2.6M	2.59M	2.56M	2.56M	2.48M	2.61M	2.56M	2.43M	1.77M	4.8M	4.98M	1.21M	-34.83M	1.03M	-13.63M
Receivables	1.17M	n/a	n/a	900K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-2.8M	-2M	-500K	-800K	n/a	n/a	n/a	-200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.29M	3.35M	2.93M	900K	3.52M	5.74M	4.8M	5.23M	3.86M	3.7M	4.93M	5.19M	n/a	9.6M	3.16M	4.54M	n/a	n/a	12K	n/a	n/a	n/a
Total Current Assets	50.81M	57.15M	76.63M	95.06M	105.53M	125.47M	130.67M	131.61M	172.75M	174.83M	181.26M	196.09M	189.16M	222.49M	248.15M	271.21M	25.36M	39.68M	54.63M	34.83M	35.9M	13.63M
Property-Plant & Equipment	24.89M	20.32M	21.64M	22.85M	24.08M	25.14M	26.23M	27.39M	28.52M	29.68M	29.13M	29.91M	30.6M	30.87M	30.55M	15.42M	16.38M	17.08M	12.31M	n/a	11.52M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	48.82M	52.19M	47.55M	47.84M	54.25M	49.89M	60.03M	74.57M	55.06M	70.68M	78.97M	86.7M	118.56M	111.06M	98.92M	53.43M	21.18M	22.06M	13.51M	-34.83M	12.55M	-13.63M
Total Assets	99.63M	109.33M	124.18M	142.89M	159.78M	175.35M	190.7M	206.18M	227.81M	245.5M	260.24M	282.79M	307.72M	333.55M	347.07M	324.64M	46.54M	61.74M	68.14M	n/a	48.45M	n/a
Account Payables	1.51M	1.48M	2.63M	2.22M	2.99M	3.68M	3.44M	1.83M	3.59M	3.83M	3.36M	4.45M	3.57M	5.16M	1.61M	2.89M	1.6M	3.4M	1.84M	n/a	2.1M	n/a
Deferred Revenue	3.02M	1.97M	2.02M	1.91M	2.2M	1.94M	1.69M	1.6M	1.99M	3.17M	3.51M	3.45M	2.87M	5.21M	4.33M	1.5M	1.5M	1.5M	n/a	n/a	599K	n/a
Short-Term Debt	n/a	-94K	3M	n/a	2.78M	2.68M	2.58M	2.48M	n/a	2.38M	2.15M	2.06M	n/a	2.41M	2.32M	1.63M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.2M	3.25M	4.37M	7.01M	3.88M	2.88M	3.76M	-136K	4.8M	1.71M	882K	4.92M	7.5M	4.57M	6.25M	2.71M	3.78M	1.72M	1.5M	n/a	1.41M	n/a
Total Current Liabilities	15.86M	18.08M	17.9M	16.72M	20.46M	18.75M	17.62M	16.25M	23.12M	24.17M	18.62M	19.31M	21.33M	23.7M	19.25M	12.01M	11.26M	9.9M	7.95M	n/a	8.66M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-77.5M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	1.00	43K	43K	43K	43K	42K	200K	200K	204K	210K	217K	233K	321K	130.85M	116.75M	69K	n/a	-77.43M	n/a
Total Long-Term Liabilities	26.58M	19.22M	20.42M	22.01M	26.59M	28.34M	30.95M	32.24M	33.18M	32.88M	33.65M	35.09M	36.27M	34.94M	31.93M	9.38M	140.22M	126.42M	6.4M	n/a	85.64M	n/a
Total Liabilities	42.43M	37.3M	38.32M	38.73M	47.04M	47.1M	48.56M	48.49M	56.3M	57.06M	52.27M	54.4M	57.6M	58.64M	51.18M	21.39M	151.49M	136.32M	14.35M	n/a	94.29M	n/a
Total Debt	25.21M	18.18M	18.89M	19.57M	20.22M	20.86M	21.47M	22.05M	22.61M	23.24M	22.89M	23.37M	24.36M	24.93M	25.48M	10.68M	10.88M	11.02M	6.33M	n/a	10.19M	n/a
Common Stock	n/a	1K	1K	1K	1K	1K	1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-427.4M	-411.47M	-396.29M	-375.1M	-364.29M	-346.38M	-330.13M	-312.07M	-295.09M	-275.09M	-253.33M	-230.67M	-206.99M	-179.83M	-156.44M	-132.85M	-108.4M	-77.36M	-67.36M	n/a	-47.67M	n/a
Comprehensive Income	97K	n/a	-44K	-36K	37K	-174K	-229K	-235K	-919K	-1.71M	-1.8M	-1.4M	-321K	-38K	-23K	-64K	n/a	2K	1K	-45.85M	n/a	-15.94M
Shareholders Equity	57.2M	72.03M	85.86M	104.16M	112.74M	128.26M	142.13M	157.69M	171.51M	188.45M	207.97M	228.39M	250.12M	274.91M	295.9M	303.25M	-104.95M	-74.59M	53.79M	31.66M	-45.85M	12.93M
Total Investments	63M	75.03M	91.33M	110.31M	119.56M	132.2M	143.63M	156.13M	183.59M	198.94M	201M	201.19M	244.18M	266.88M	252.62M	207.42M	17.3M	19.95M	8.04M	69.65M	n/a	27.27M